Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jul-Sep;24(3):308-312.
doi: 10.4103/IJPC.IJPC_1_18.

Palliation of Brain Metastases: Analysis of Prognostic Factors Affecting Overall Survival

Kartick Rastogi  1 , Sandeep Bhaskar  1 , Shivani Gupta  1 , Sandeep Jain  1 , Daleep Singh  1 , Pawan Kumar  1
Affiliations

Palliation of Brain Metastases: Analysis of Prognostic Factors Affecting Overall Survival

Kartick Rastogi et al. Indian J Palliat Care. 2018 Jul-Sep.

Abstract

Context: Brain metastasis is one of the most feared complications of cancer that poses significant mortality and morbidity in patients with advanced cancer. The incidence is rising because of greater use of magnetic resonance imaging and spectroscopy; and increased survival from recent advances in immunotherapy and modern radiotherapy techniques. Despite all, the prognosis remains poor.

Aims: This study aimed to analyze prognostic factors and overall survival in patients with brain metastases.

Subjects and methods: A total of 145 patients were analyzed from July 2014 to June 2015 for various prognostic factors prospectively. Survival analysis was done using Kaplan-Meier curve.

Results: The median overall survival was 6 months, while 1- and 2-year survival rates were 8.3% and 1.4%, respectively. Median survival was highest with surgery followed by radiotherapy (11 months). Whole-brain radiotherapy (WBRT) significantly improved the survival (P = 0.006). The most common primary was lung cancer (58%) and the most common histology was adenocarcinoma (36%). Most patients (38%) were diagnosed upfront with brain metastases. Most of the lesions were multiple (80%) and located in cerebrum (58%). Survival was significantly improved with female gender (P = 0.003), Eastern Cooperative Oncology Group performance status (PS) 0-2 (P = 0.006), breast primary (P = 0.004), time lag of >6 months (P < 0.001), solitary lesion (P = 0.002), and controlled primary (P = 0.017).

Conclusions: WBRT remains the cornerstone of the management of brain metastases. The present study concludes that the survival of patients with brain metastases is significantly improved with female gender, good PS, primary breast cancer, time lag of >6 months between diagnosis of the primary tumor and development of brain metastases, solitary lesion, and controlled primary tumor.

Keywords: Brain metastases; survival; whole-brain radiotherapy.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Kaplan–Meier survival plot of the patients with brain metastases
See this image and copyright information in PMC

References

    1. Victor TS. Brain Metastasis. Medscape Reference. [Last accessed on 2016 May 05]. Available from: http://www.emedicine.medscape.com/article .
    1. Posner JB. Brain metastases: 1995. A brief review. J Neurooncol. 1996;27:287–93. - PubMed
    1. Lagerwaard FJ, Levendag PC, Nowak PJ, Eijkenboom WM, Hanssens PE, Schmitz PI, et al. Identification of prognostic factors in patients with brain metastases: A review of 1292 patients. Int J Radiat Oncol Biol Phys. 1999;43:795–803. - PubMed
    1. Wen PY, Loeffler JS. Management of brain metastases. Oncology (Williston Park) 1999;13:941–54. 957-61. - PubMed
    1. Davis PC, Hudgins PA, Peterman SB, Hoffman JC., Jr Diagnosis of cerebral metastases: Double-dose delayed CT vs. contrast-enhanced MR imaging. AJNR Am J Neuroradiol. 1991;12:293–300. - PMC - PubMed